Fusion Pharmaceuticals (FUSN)
(Delayed Data from NSDQ)
$21.51 USD
+0.05 (0.23%)
Updated May 17, 2024 04:00 PM ET
After-Market: $21.50 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | -5.26% |
ABR | 3.00 |
Earnings ESP
|
2.70% |
---|---|
Current Year | -1.44 |
Next Year | -1.66 |
EPS (TTM) | -1.42 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.20M | 1.10M | 11.20M | 1.00M |
# of Estimates | 1 | 2 | 4 | 1 |
High Estimate | 0.20M | 2.00M | 40.00M | 1.00M |
Low Estimate | 0.20M | 0.20M | 0.70M | 1.00M |
Year ago Sales | 0.03M | 2.01M | 2.07M | 11.20M |
Year over Year Growth Est. | 566.67% | -45.27% | 441.59% | -91.07% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.36 | -1.44 | -1.66 |
# of Estimates | 6 | 6 | 11 | 6 |
Most Recent Consensus | -0.39 | -0.39 | -1.58 | -1.65 |
High Estimate | -0.28 | -0.30 | -1.08 | -1.29 |
Low Estimate | -0.44 | -0.41 | -1.79 | -1.93 |
Year ago EPS | -0.38 | -0.25 | -1.45 | -1.44 |
Year over Year Growth Est. | 2.63% | -44.00% | 0.69% | -14.97% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 3 |
Up Last 60 Days | 1 | 1 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 2 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.36 | -1.44 | -1.66 |
7 Days Ago | -0.37 | -0.36 | -1.44 | -1.66 |
30 Days Ago | -0.38 | -0.38 | -1.46 | -1.69 |
60 Days Ago | -0.34 | -0.34 | -1.39 | -1.58 |
90 Days Ago | -0.34 | -0.34 | -1.39 | -1.58 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.36 | -1.57 | -1.78 |
Zacks Consensus Estimate | -0.37 | -0.36 | -1.44 | -1.66 |
Earnings ESP | 2.70% | 0.46% | -8.82% | -7.54% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.39 | -0.25 | -0.38 | NA |
Estimate | -0.38 | -0.34 | -0.40 | -0.39 | NA |
Difference | -0.02 | -0.05 | 0.15 | 0.01 | 0.02 |
Surprise | -5.26% | -14.71% | 37.50% | 2.56% | 5.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more